Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > # of NR Patients in Swimmer Plots (May 10th & May 30th)

<< Previous

Bullboard Posts

Next >>

Post by RoseHeavenon May 31, 2023 12:25am

286 Views

Post# 35471651

# of NR Patients in Swimmer Plots (May 10th & May 30th)

May 10th Swimmer's plot had 25 NR patients at 450D whereas today's Swimmers plot reported 24 NR. It means, 1 of the previously reported NR patients recclassified to either CR or NR.

I was comparing the sequence of responses from 90D to 450D in both Swimmer's plots but could not identify the NR patient that converted to CR or IR. It's a good news story but wanted to know for the sake of understanding.

Will appreciate if anybody could figure this out!

Cheers long.

RH

<< Previous

Bullboard Posts

Next >>

Ivanhoe Mines initiates Phase 3 concentrator construction